| Human induced pluripotent stem cell–derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes I Karakikes, M Ameen, V Termglinchan, JC Wu Circulation research 117 (1), 80-88, 2015 | 479 | 2015 |
| Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy I Karakikes, F Stillitano, M Nonnenmacher, C Tzimas, D Sanoudou, ... Nature communications 6 (1), 6955, 2015 | 199 | 2015 |
| Patient-specific iPSC-derived endothelial cells uncover pathways that protect against pulmonary hypertension in BMPR2 mutation carriers M Gu, NY Shao, S Sa, D Li, V Termglinchan, M Ameen, I Karakikes, ... Cell stem cell 20 (4), 490-504. e5, 2017 | 198 | 2017 |
| iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy K Kodo, SG Ong, F Jahanbani, V Termglinchan, K Hirono, ... Nature cell biology 18 (10), 1031-1042, 2016 | 179 | 2016 |
| Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro E Matsa, PW Burridge, KH Yu, JH Ahrens, V Termglinchan, H Wu, C Liu, ... Cell stem cell 19 (3), 311-325, 2016 | 169 | 2016 |
| Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy J Lee, V Termglinchan, S Diecke, I Itzhaki, CK Lam, P Garg, E Lau, ... Nature 572 (7769), 335-340, 2019 | 159 | 2019 |
| Autologous iPSC-based vaccines elicit anti-tumor responses in vivo NG Kooreman, Y Kim, PE de Almeida, V Termglinchan, S Diecke, ... Cell stem cell 22 (4), 501-513. e7, 2018 | 157 | 2018 |
| A human iPSC double-reporter system enables purification of cardiac lineage subpopulations with distinct function and drug response profiles JZ Zhang, V Termglinchan, NY Shao, I Itzhaki, C Liu, N Ma, L Tian, ... Cell Stem Cell 24 (5), 802-811. e5, 2019 | 119 | 2019 |
| Novel codon-optimized mini-intronic plasmid for efficient, inexpensive and xeno-free induction of pluripotency S Diecke, J Lu, J Lee, V Termglinchan, NG Kooreman, PW Burridge, ... Scientific reports 5 (1), 8081, 2015 | 81 | 2015 |
| A comprehensive TALEN-based knockout library for generating human-induced pluripotent stem cell–based models for cardiovascular diseases I Karakikes, V Termglinchan, DA Cepeda, J Lee, S Diecke, A Hendel, ... Circulation Research 120 (10), 1561-1571, 2017 | 63 | 2017 |
| Telomere shortening is a hallmark of genetic cardiomyopathies ACY Chang, ACH Chang, A Kirillova, K Sasagawa, W Su, G Weber, J Lin, ... Proceedings of the National Academy of Sciences 115 (37), 9276-9281, 2018 | 61 | 2018 |
| SETD7 drives cardiac lineage commitment through stage-specific transcriptional activation J Lee, NY Shao, DT Paik, H Wu, H Guo, V Termglinchan, JM Churko, ... Cell Stem Cell 22 (3), 428-444. e5, 2018 | 49 | 2018 |
| Human-induced pluripotent stem cell models of inherited cardiomyopathies I Karakikes, V Termglinchan, JC Wu Current opinion in cardiology 29 (3), 214-219, 2014 | 34 | 2014 |
| Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy I Perea-Gil, T Seeger, AAN Bruyneel, V Termglinchan, E Monte, EW Lim, ... European Heart Journal 43 (36), 3477-3489, 2022 | 27 | 2022 |
| Concise review: mending a broken heart: the evolution of biological therapeutics C Chen, V Termglinchan, I Karakikes Stem cells 35 (5), 1131-1140, 2017 | 13 | 2017 |
| Identifying solutions to meet unmet needs of family caregivers using human-centered design V Termglinchan, S Daswani, P Duangtaweesub, T Assavapokee, ... BMC geriatrics 22 (1), 94, 2022 | 7 | 2022 |
| Candidate cancer-targeting agents identified by expression-profiling arrays V Termglinchan, W Wanichnopparat, K Suwanwongse, C Teeyapant, ... OncoTargets and therapy, 447-458, 2013 | 6 | 2013 |
| Efficient genome editing in induced pluripotent stem cells with engineered nucleases in vitro V Termglinchan, T Seeger, C Chen, JC Wu, I Karakikes Cardiac Gene Therapy: Methods and Protocols, 55-68, 2017 | 5 | 2017 |
| Current status of genome editing in cardiovascular medicine V Termglinchan, I Karakikes, T Seeger, JC Wu Genome editing, 107-126, 2016 | 4 | 2016 |
| Recent advances in cardiac gene therapy strategies targeting advanced heart failure C Chen, T Seeger, V Termglinchan, I Karakikes Continuing Cardiology Education 3 (4), 163-169, 2017 | 3 | 2017 |
